<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39334997</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2079-6382</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>30</Day></PubDate></JournalIssue><Title>Antibiotics (Basel, Switzerland)</Title><ISOAbbreviation>Antibiotics (Basel)</ISOAbbreviation></Journal><ArticleTitle>The Profile of Bacterial Infections in a Burn Unit during and after the COVID-19 Pandemic Period.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">823</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/antibiotics13090823</ELocationID><Abstract><AbstractText>Infections represent a major complication for burn-injured patients. The aim of this study was to highlight the changes in the incidence and antimicrobial resistance of bacterial strains isolated from burn patients, at the end of the COVID-19 pandemic, in relation to the antibiotics used during the pandemic. A comparative analysis of the demographic data and the microorganisms identified in the clinical samples of two groups of burn patients admitted to a university hospital in Romania was carried out. The first group consisted of 48 patients and the second of 69 patients, hospitalized in January-August 2020 and 2023, respectively. The bacterial species with the highest incidence were <i>S. aureus</i>, <i>A. baumannii</i>, <i>Pseudomonas</i> spp. The significant changes between 2023 and 2020 are reflected in the increase in the frequency of non-fermentative Gram-negative bacteria, especially <i>S. maltophilia</i>, and the increase in antimicrobial resistance of <i>Pseudomonas</i> and <i>Klebsiella</i> spp. <i>Klebsiella</i> spp. did not change in frequency (7%), but there was a significant increase in the incidence of <i>K. pneumoniae</i> strains with pan-drug resistant behaviour to antibiotics (40%), including colistin. The phenomenon can be explained by the selection of specimens carrying multiple resistance genes, as a result of antibiotic treatment during the COVID-19 period. The post-pandemic antimicrobial resistance detected in burn patients indicates the need for permanent surveillance of the resistance trends, primarily due to the limited therapeutic options available for these patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Musuroi</LastName><ForeName>Corina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Multidisciplinary Research Center of Antimicrobial Resistance, Microbiology Department, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microbiology Laboratory, "Pius Brinzeu" County Clinical Emergency Hospital, 300723 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musuroi</LastName><ForeName>Silvia-Ioana</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Doctoral School, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baditoiu</LastName><ForeName>Luminita</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1572-1196</Identifier><AffiliationInfo><Affiliation>Epidemiology Department, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crainiceanu</LastName><ForeName>Zorin</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-2880-7485</Identifier><AffiliationInfo><Affiliation>Department of Plastic Surgery, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muntean</LastName><ForeName>Delia</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9100-4530</Identifier><AffiliationInfo><Affiliation>Multidisciplinary Research Center of Antimicrobial Resistance, Microbiology Department, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microbiology Laboratory, "Pius Brinzeu" County Clinical Emergency Hospital, 300723 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voinescu</LastName><ForeName>Adela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Multidisciplinary Research Center of Antimicrobial Resistance, Microbiology Department, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microbiology Laboratory, "Pius Brinzeu" County Clinical Emergency Hospital, 300723 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral School, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izmendi</LastName><ForeName>Oana</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-7644-8109</Identifier><AffiliationInfo><Affiliation>Multidisciplinary Research Center of Antimicrobial Resistance, Microbiology Department, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral School, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sirmon</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Epidemiology Department, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Department, "Pius Brinzeu" County Clinical Emergency Hospital, 300723 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Licker</LastName><ForeName>Monica</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9245-5883</Identifier><AffiliationInfo><Affiliation>Multidisciplinary Research Center of Antimicrobial Resistance, Microbiology Department, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microbiology Laboratory, "Pius Brinzeu" County Clinical Emergency Hospital, 300723 Timisoara, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Antibiotics (Basel)</MedlineTA><NlmUniqueID>101637404</NlmUniqueID><ISSNLinking>2079-6382</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antimicrobial resistance</Keyword><Keyword MajorTopicYN="N">burn</Keyword><Keyword MajorTopicYN="N">non-fermenting Gram-negative bacteria</Keyword><Keyword MajorTopicYN="N">pandemic period</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39334997</ArticleId><ArticleId IdType="pmc">PMC11428671</ArticleId><ArticleId IdType="doi">10.3390/antibiotics13090823</ArticleId><ArticleId IdType="pii">antibiotics13090823</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Branski L.K., Al-Mousawi A., Rivero H., Jeschke M.G., Sanford A.P., Herndon D.N. Emerging infections in burns. Surg. Infect. 2009;10:389–397. doi: 10.1089/sur.2009.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/sur.2009.024</ArticleId><ArticleId IdType="pmc">PMC2956561</ArticleId><ArticleId IdType="pubmed">19810827</ArticleId></ArticleIdList></Reference><Reference><Citation>Vindenes H., Bjerknes R. Microbial colonization of large wounds. Burns. 1995;21:575–579. doi: 10.1016/0305-4179(95)00047-F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0305-4179(95)00047-F</ArticleId><ArticleId IdType="pubmed">8747728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravat F., Le-Floch R., Vinsonneau C., Ainaud P., Bertin-Maghit M., Carsin H., Perro G. Antibiotics and the burn patient. Burns. 2011;37:16–26. doi: 10.1016/j.burns.2009.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.burns.2009.10.006</ArticleId><ArticleId IdType="pubmed">20510518</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez M.R., Ducret V., Leoni S., Fleuchot B., Jafari P., Raffoul W., Applegate L.A., Que Y.-A., Perron K. Transcriptome Analysis of Pseudomonas aeruginosa Cultured in Human Burn Wound Exudates. Front. Cell. Infect. Microbiol. 2018;8 doi: 10.3389/fcimb.2018.00039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2018.00039</ArticleId><ArticleId IdType="pmc">PMC5835353</ArticleId><ArticleId IdType="pubmed">29535973</ArticleId></ArticleIdList></Reference><Reference><Citation>Malone M., Bjarnsholt T., McBain A.J., James G.A., Stoodley P., Leaper D., Tachi M., Schultz G., Swanson T., Wolcott R.D. The prevalence of biofilms in chronic wounds: A systematic review and meta-analysis of published data. J. Wound Care. 2017;26:20–25. doi: 10.12968/jowc.2017.26.1.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.12968/jowc.2017.26.1.20</ArticleId><ArticleId IdType="pubmed">28103163</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjarnsholt T., Kirketerp-Møller K., Jensen P.Ø., Madsen K.G., Phipps R., Krogfelt K., Høiby N., Givskov M. Why chronic wounds will not heal: A novel hypothesis. Wound Repair Regen. 2008;16:2–10. doi: 10.1111/j.1524-475X.2007.00283.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1524-475X.2007.00283.x</ArticleId><ArticleId IdType="pubmed">18211573</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser C., Jensen P.Ø., Thomsen K., Kolpen M., Rybtke M., Lauland A.S., Trøstrup H., Tolker-Nielsen T. Immune Responses to Pseudomonas aeruginosa Biofilm Infections. Front. Immunol. 2021;12:625597. doi: 10.3389/fimmu.2021.625597.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.625597</ArticleId><ArticleId IdType="pmc">PMC7937708</ArticleId><ArticleId IdType="pubmed">33692800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirketerp-Møller K., Stewart P.S., Bjarnsholt T. The zone model: A conceptual model for understanding the microenvironment of chronic wound infection. Wound Repair Regen. 2020;28:593–599. doi: 10.1111/wrr.12841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/wrr.12841</ArticleId><ArticleId IdType="pmc">PMC7540265</ArticleId><ArticleId IdType="pubmed">32529778</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslova E., Eisaiankhongi L., Sjöberg F., McCarthy R.R. Burns and biofilms: Priority pathogens and in vivo models. NPJ Biofilms Microbiomes. 2021;7:73. doi: 10.1038/s41522-021-00243-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41522-021-00243-2</ArticleId><ArticleId IdType="pmc">PMC8429633</ArticleId><ArticleId IdType="pubmed">34504100</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandenburg K.S., Weaver A.J., Karna S.L.R., Leung K.P. The impact of simultaneous inoculation of Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans on rodent burn wounds. Burns. 2021;47:1818–1832. doi: 10.1016/j.burns.2021.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.burns.2021.02.025</ArticleId><ArticleId IdType="pubmed">33771422</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandenburg K.S., Weaver A.J., Karna S.L.R., You T., Chen P., Van Stryk S., Qian L., Pineda U., Abercrombie J.J., Leung K.P. Formation of Pseudomonas aeruginosa Biofilms in Full-thickness Scald Burn Wounds in Rats. Sci. Rep. 2019;9:13627. doi: 10.1038/s41598-019-50003-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-50003-8</ArticleId><ArticleId IdType="pmc">PMC6754504</ArticleId><ArticleId IdType="pubmed">31541159</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy P., Brammah S., Wills E. Burns, biofilm and a new appraisal of burn wound sepsis. Burns. 2010;36:49–56. doi: 10.1016/j.burns.2009.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.burns.2009.02.017</ArticleId><ArticleId IdType="pubmed">19523770</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen I. Biofilm-specific antibiotic tolerance and resistance. Eur. J. Clin. Microbiol. Infect. Dis. 2015;34:877–886. doi: 10.1007/s10096-015-2323-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-015-2323-z</ArticleId><ArticleId IdType="pubmed">25630538</ArticleId></ArticleIdList></Reference><Reference><Citation>Foncerrada G., Culnan D.M., Capek K.D., González-Trejo S., Cambiaso-Daniel J., Woodson L.C., Herndon D.N., Finnerty C.C., Lee J.O. Inhalation Injury in the Burned Patient. Ann. Plast. Surg. 2018;80:S98–S105. doi: 10.1097/SAP.0000000000001377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SAP.0000000000001377</ArticleId><ArticleId IdType="pmc">PMC5825291</ArticleId><ArticleId IdType="pubmed">29461292</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehm D., Menke H. Sepsis in Burns—Lessons Learnt from Developments in the Management of Septic Shock. Medicina. 2022;58:26. doi: 10.3390/medicina58010026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58010026</ArticleId><ArticleId IdType="pmc">PMC8779285</ArticleId><ArticleId IdType="pubmed">35056334</ArticleId></ArticleIdList></Reference><Reference><Citation>Laura P., José A., Nikki A., Khaled A., Barret J., Jeffery C., Shobha C., Jack C.S., Scott C., Nadia D., et al. Impact of COVID-19 on global burn care. Burns. 2022;48:1301–1310. doi: 10.1016/j.burns.2021.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.burns.2021.11.010</ArticleId><ArticleId IdType="pmc">PMC8664090</ArticleId><ArticleId IdType="pubmed">34903416</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Kain R., More A., Sheth S., Arumugam P.K. Burns and COVID-19-Initial Experience and Challenges. J. Burn Care Res. 2021;42:794–800. doi: 10.1093/jbcr/iraa217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jbcr/iraa217</ArticleId><ArticleId IdType="pmc">PMC7799032</ArticleId><ArticleId IdType="pubmed">33367625</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters E.T., Palackic A., Franco-Mesa C., Shah N.R., Erickson M.J., Wolf S.E. The impact of COVID-19 on clinical outcomes of burn patients. Burn. Trauma. 2023;11:tkad042. doi: 10.1093/burnst/tkad042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/burnst/tkad042</ArticleId><ArticleId IdType="pmc">PMC10699731</ArticleId><ArticleId IdType="pubmed">38074193</ArticleId></ArticleIdList></Reference><Reference><Citation>European Centre for Disease Prevention and Control  Antimicrobial resistance surveillance in Europe 2022–2020 data, Surveill Rep [Internet] 2022.  [(accessed on 20 September 2023)].  Available online:  https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2022-2020-data.</Citation></Reference><Reference><Citation>Lima K.M., Davis R.R., Liu S.Y., Greenhalgh D.G., Tran N.K. Longitudinal profiling of the burn patient cutaneous and gastrointestinal microbiota: A pilot study. Sci. Rep. 2021;11:10667. doi: 10.1038/s41598-021-89822-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-89822-z</ArticleId><ArticleId IdType="pmc">PMC8139985</ArticleId><ArticleId IdType="pubmed">34021204</ArticleId></ArticleIdList></Reference><Reference><Citation>ECDC  Surveillance of Antimicrobial resistance in Europe Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2016.  [(accessed on 16 August 2020)].  Available online:  https://www.ecdc.europa.eu/sites/default/files/documents/AMR-surveillance-Europe-2016.pdf.</Citation></Reference><Reference><Citation>Boccabella L., Palma E.G., Abenavoli L., Scarlata G.G.M., Boni M., Ianiro G., Santori P., Tack J.F., Scarpellini E. Post-Coronavirus Disease 2019 Pandemic Antimicrobial Resistance. Antibiotics. 2024;13:233. doi: 10.3390/antibiotics13030233.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics13030233</ArticleId><ArticleId IdType="pmc">PMC10967554</ArticleId><ArticleId IdType="pubmed">38534668</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossato M., Andrisani A., Zabeo E., Di Vincenzo A. Men with COVID-19 die. Women survi at any age! Maturitas. 2022;163:88. doi: 10.1016/j.maturitas.2022.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2022.05.004</ArticleId><ArticleId IdType="pmc">PMC9212808</ArticleId><ArticleId IdType="pubmed">35934489</ArticleId></ArticleIdList></Reference><Reference><Citation>Muntean D., Horhat F.-G., Bădițoiu L., Dumitrașcu V., Bagiu I.-C., Horhat D.-I., Coșniță D.A., Krasta A., Dugăeşescu D., Licker M. Multidrug-Resistant Gram-Negative Bacilli: A Retrospective Study of Trends in a Tertiary Healthcare Unit. Medicina. 2018;54:92. doi: 10.3390/medicina54060092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina54060092</ArticleId><ArticleId IdType="pmc">PMC6307078</ArticleId><ArticleId IdType="pubmed">30486311</ArticleId></ArticleIdList></Reference><Reference><Citation>Licker M., Musuroi C., Muntean D., Crainiceanu Z. Updates in the Management of Multidrug-Resistant Bacterial Infections in Burn Patients. Proceedings [Internet] 2023.  [(accessed on 15 January 2024)].  Available online:  https://www.srm.ro/media/2023/11/volum-rezumate-cnme-1.pdf.</Citation></Reference><Reference><Citation>Gupta N., Haque A., Mukhopadhyay G., Narayan R.P., Prasad R. Interactions between bacteria and Candida in the burn wound. Burns. 2005;31:375–378. doi: 10.1016/j.burns.2004.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.burns.2004.11.012</ArticleId><ArticleId IdType="pubmed">15774298</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirtliff M.E., Peters B.M., Jabra-Rizk M.A. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol. Lett. 2009;299:1–8. doi: 10.1111/j.1574-6968.2009.01668.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6968.2009.01668.x</ArticleId><ArticleId IdType="pmc">PMC4406406</ArticleId><ArticleId IdType="pubmed">19552706</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazik H., Bektöre B., Öngen B., Ilktaç M., Özyurt M., Kuvat N., Baylan O., Keküllüoglu H., Haznedaroglu T., Kelesoglu F.M. Plasmid-Mediated Quinolone Resistance Genes in Escherichia coli Urinary Isolates from Two Teaching Hospitals in Turkey: Coexistence of TEM, SHV, CTX-M and VEB-1 Type β-lactamases. Trop. J. Pharm. Res. 2011;10:325–333. doi: 10.4314/tjpr.v10i3.9.</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/tjpr.v10i3.9</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E.J., Kim Y.C., Ahn J.Y., Jeong S.J., Ku N.S., Choi J.Y., Yeom J.-S., Song Y.G. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains. BMC Infect. Dis. 2019;19:754. doi: 10.1186/s12879-019-4394-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-019-4394-4</ArticleId><ArticleId IdType="pmc">PMC6714101</ArticleId><ArticleId IdType="pubmed">31462215</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumwenda G.P., Kasambara W., Chizani K., Phiri A., Banda A., Choonara F., Lichapa B. A multidrug-resistant Stenotrophomonas maltophilia clinical isolate from Kamuzu Central Hospital, Malawi. Malawi Med. J. 2021;33:82–84. doi: 10.4314/mmj.v33i2.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/mmj.v33i2.3</ArticleId><ArticleId IdType="pmc">PMC8560359</ArticleId><ArticleId IdType="pubmed">34777703</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooke J.S. New strategies against Stenotrophomonas maltophilia: A serious worldwide intrinsically drug-resistant opportunistic pathogen. Expert Rev. Anti-Infect. Ther. 2014;12:1–4. doi: 10.1586/14787210.2014.864553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14787210.2014.864553</ArticleId><ArticleId IdType="pubmed">24308713</ArticleId></ArticleIdList></Reference><Reference><Citation>Adegoke A.A., Stenström T.A., Okoh A.I. Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy. Front. Microbiol. 2017;8:2276. doi: 10.3389/fmicb.2017.02276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.02276</ArticleId><ArticleId IdType="pmc">PMC5714879</ArticleId><ArticleId IdType="pubmed">29250041</ArticleId></ArticleIdList></Reference><Reference><Citation>Pogson K., Nurczyk K., Sljivic S., Jones S.W., Cairns B., Nizamani R., Chrisco L., Williams F.N. 716 Increased Mortality in Burn Center Admissions with Stenotrophomonas Maltophilia. J. Burn Care Res. 2020;41((Suppl. S1)):S189–S190. doi: 10.1093/jbcr/iraa024.302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jbcr/iraa024.302</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooke J.S. Advances in the Microbiology of Stenotrophomonas maltophilia. Clin. Microbiol. Rev. 2021;34:e0003019. doi: 10.1128/CMR.00030-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00030-19</ArticleId><ArticleId IdType="pmc">PMC8262804</ArticleId><ArticleId IdType="pubmed">34043457</ArticleId></ArticleIdList></Reference><Reference><Citation>Panghal M., Singh K., Kadyan S., Chaudary U., Yadav J.P. The analysis of distribution of multidrug resistant Pseudomonas and Bacillus species from burn patients and burn ward environment. Burns. 2015;41:812–819. doi: 10.1016/j.burns.2014.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.burns.2014.10.014</ArticleId><ArticleId IdType="pubmed">25468476</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  COVID-19 Impacts on Antimicrobial Resistance.  [(accessed on 7 June 2024)];2024  Available online:  https://www.cdc.gov/antimicrobial-resistance/data-research/threats/COVID-19.html.</Citation></Reference><Reference><Citation>Abdelaziz Abdelmoneim S., Mohamed Ghazy R., Anwar Sultan E., Hassaan M.A., Anwar Mahgoub M. Antimicrobial resistance burden pre and post-COVID-19 pandemic with mapping the multidrug resistance in Egypt: A comparative cross-sectional study. Sci. Rep. 2024;14:7176. doi: 10.1038/s41598-024-56254-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-56254-4</ArticleId><ArticleId IdType="pmc">PMC10966009</ArticleId><ArticleId IdType="pubmed">38531847</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodríguez-Baño J., Rossolini G.M., Schultsz C., Tacconelli E., Murthy S., Ohmagari N., Holmes A., Bachmann T., Goossens H., Canton R., et al. Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic. J. Glob. Antimicrob. Resist. 2021;25:5–7. doi: 10.1016/j.jgar.2021.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgar.2021.02.013</ArticleId><ArticleId IdType="pmc">PMC7919515</ArticleId><ArticleId IdType="pubmed">33662647</ArticleId></ArticleIdList></Reference><Reference><Citation>Institutul Național de Sănătate Publică  Infectii Asociate Asistentei Medicale, Rezistenta Microbiana, Consum Antibiotice-CARMIAAN.  [(accessed on 23 June 2024)]; Available online:  https://insp.gov.ro/centrul-national-de-supraveghere-si-control-al-bolilor-transmisibile-cnscbt/analiza-date-supraveghere/</Citation></Reference><Reference><Citation>Chaïbi K., de Ponfilly G., Dortet L., Zahar J.-R., Pilmis B. Empiric Treatment in HAP/VAP: “Don’t You Want to Take a Leap of Faith”? Antibiotics. 2022;11:359. doi: 10.3390/antibiotics11030359.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics11030359</ArticleId><ArticleId IdType="pmc">PMC8944836</ArticleId><ArticleId IdType="pubmed">35326822</ArticleId></ArticleIdList></Reference><Reference><Citation>Novacescu A.N., Buzzi B., Bedreag O., Papurica M., Rogobete A.F., Sandesc D., Sorescu T., Baditoiu L., Musuroi C., Vlad D., et al. Bacterial and Fungal Superinfections in COVID-19 Patients Hospitalized in an Intensive Care Unit from Timișoara, Romania. Infect. Drug Resist. 2022;15:7001–7014. doi: 10.2147/IDR.S390681.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S390681</ArticleId><ArticleId IdType="pmc">PMC9721122</ArticleId><ArticleId IdType="pubmed">36478964</ArticleId></ArticleIdList></Reference><Reference><Citation>Boattini M., Bianco G., Llorente L.I., Acero L.A., Nunes D., Seruca M., Mendes V.S., Almeida A., Bastos P., Rodríguez-Villodres Á., et al. Enterobacterales carrying chromosomal AmpC β-lactamases in Europe (EuESCPM): Epidemiology and antimicrobial resistance burden from a cohort of 27 hospitals, 2020–2022. Int. J. Antimicrob. Agents. 2024;63:107115. doi: 10.1016/j.ijantimicag.2024.107115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2024.107115</ArticleId><ArticleId IdType="pubmed">38367844</ArticleId></ArticleIdList></Reference><Reference><Citation>Bittner E.A., Shank E., Woodson L., Martyn J.A.J. Acute and Perioperative Care of the Burn-injured Patient. Anesthesiology. 2015;122:448–464. doi: 10.1097/ALN.0000000000000559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000559</ArticleId><ArticleId IdType="pmc">PMC4844008</ArticleId><ArticleId IdType="pubmed">25485468</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobiasen J., Hiebert J.M., Edlich R.F. The abbreviated burn severity index. Ann. Emerg. Med. 1982;11:260–262. doi: 10.1016/S0196-0644(82)80096-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0196-0644(82)80096-6</ArticleId><ArticleId IdType="pubmed">7073049</ArticleId></ArticleIdList></Reference><Reference><Citation>Usmani A., Pipal D.K., Bagla H., Verma V., Kumar P., Yadav S., Garima G., Rani V., Pipal R.K. Prediction of Mortality in Acute Thermal Burn Patients Using the Abbreviated Burn Severity Index Score: A Single-Center Experience. Cureus. 2022;14:26161. doi: 10.7759/cureus.26161.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.26161</ArticleId><ArticleId IdType="pmc">PMC9302604</ArticleId><ArticleId IdType="pubmed">35891871</ArticleId></ArticleIdList></Reference><Reference><Citation>EUCAST  Breakpoint Tables for Interpretation of MICs and Zone Diameters Version 13.0.  [(accessed on 17 January 2024)].  Available online:  https://www.eucast.org/clinical_breakpoints.</Citation></Reference><Reference><Citation>CLSI  Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st ed.; 2021.  [(accessed on 25 February 2020)].  Available online:  https://clsi.org/media/z2uhcbmv/m100ed31_sample.pdf.</Citation></Reference><Reference><Citation>Magiorakos A.-P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., Harbarth S., Hindler J.F., Kahlmeter G., Olsson-Liljequist B., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012;18:268–281. doi: 10.1111/j.1469-0691.2011.03570.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2011.03570.x</ArticleId><ArticleId IdType="pubmed">21793988</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>